Back
Leap Therapeutics Stock Price Chart

Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
8
LPTX
Leap Therapeutics
Last Price:
$0.40
Seasonality Move:
9.9%
7 Day Trial
ALL ACCESS PASS
$
7

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LPTX is experiencing slight buying pressure.
Leap Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.41 | Sell |
20-day SMA: | 0.43 | Sell |
50-day SMA: | 1.13 | Sell |
200-day SMA: | 2.26 | Sell |
8-day EMA: | 0.41 | Sell |
20-day EMA: | 0.49 | Sell |
50-day EMA: | 1.03 | Sell |
200-day EMA: | 2.13 | Sell |
Leap Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 24.34 | Sell |
Chaikin Money Flow: | 35876 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.41 - 0.49) | Sell |
Bollinger Bands (100): | (0.83 - 3.43) | Sell |
Leap Therapeutics Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Leap Therapeutics Stock
Is Leap Therapeutics Stock a Buy?
-
Leap Therapeutics share price is 0.40 while LPTX 8-day simple moving average is 0.41, which is a Sell signal.
-
The stock price of LPTX is 0.40 while Leap Therapeutics 20-day SMA is 0.43, which makes it a Sell.
-
Leap Therapeutics 50-day simple moving average is 1.13 while LPTX share price is 0.40, making it a Sell technically.
-
LPTX stock price is 0.40 and Leap Therapeutics 200-day simple moving average is 2.26, creating a Sell signal.
LPTX Technical Analysis vs Fundamental Analysis
Sell
8
Leap Therapeutics (LPTX)
is a Sell
Is Leap Therapeutics a Buy or a Sell?
-
Leap Therapeutics stock is rated a SellThe current Leap Therapeutics [LPTX] share price is $0.40. The Score for LPTX is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
Leap Therapeutics Stock Info
Market Cap:
15.4M
Price in USD:
0.40
Share Volume:
227.2K
Leap Therapeutics 52-Week Range
52-Week High:
4.79
52-Week Low:
0.39
Sell
8
Leap Therapeutics (LPTX)
is a Sell
Leap Therapeutics Share Price Forecast
-
What is the Leap Therapeutics stock price today?The Leap Therapeutics stock price is 0.40 USD today.
-
Will LPTX stock go up or go down?Leap Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Leap Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Leap Therapeutics is overvalued.
Is Leap Therapeutics Stock a Buy?
-
Leap Therapeutics share price is 0.40 while LPTX 8-day exponential moving average is 0.41, which is a Sell signal.
-
The stock price of LPTX is 0.40 while Leap Therapeutics 20-day EMA is 0.49, which makes it a Sell.
-
Leap Therapeutics 50-day exponential moving average is 1.03 while LPTX share price is 0.40, making it a Sell technically.
-
LPTX stock price is 0.40 and Leap Therapeutics 200-day simple moving average is 2.13, creating a Sell signal.
Fundamental Analysis of Leap Therapeutics
Is Leap Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.04 per share.
Technical Analysis of Leap Therapeutics
Should I short Leap Therapeutics stock?
-
LPTX Moving Average Covergence Divergence (MACD) indicator is -0.16, suggesting Leap Therapeutics is a Sell
-
Leap Therapeutics Relative Strength Index (RSI) is 24.34, which suggest Leap Therapeutics is oversold
-
The Bollinger Bands (25) for Leap Therapeutics is (0.41 - 0.49), which suggest Leap Therapeutics is a Sell
-
The Bollinger Bands (100) for Leap Therapeutics is (0.83 - 3.43), which suggest Leap Therapeutics is a Sell
* Leap Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.